Try our beta test site
287 studies found for:    cholangiocarcinoma
Show Display Options
Rank Status Study
1 Enrolling by invitation Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Biological: Oral therapeutic vaccine V3-X to treat cholangiocarcinoma
2 Completed
Has Results
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: CT scan
3 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
4 Unknown  Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Everolimus
5 Recruiting Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: FOLFIRINOX
6 Completed S-1 and Photodynamic Therapy in Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: S-1 Chemotherapy;   Procedure: Photodynamic therapy;   Procedure: Systemic chemotherapy except S-1
7 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
8 Withdrawn Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Condition: Cholangiocarcinoma
Intervention:
9 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
10 Unknown  Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition: Cholangiocarcinoma
Intervention: Drug: RAD001
11 Recruiting Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Procedure: conventional lymph node dissection;   Procedure: unconventional lymph node dissection
12 Completed Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine
13 Completed A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma
Condition: Unresectable and Advanced Cholangiocarcinoma
Intervention: Drug: Sunitinib
14 Recruiting Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors
Condition: Cholangiocarcinoma
Intervention:
15 Unknown  Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition: Unresectable Hilar Cholangiocarcinoma
Intervention: Device: biliary stent
16 Active, not recruiting Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: Therasphere® in association with Gemcitabine and Cisplatin
17 Active, not recruiting Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Dasatinib
18 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
19 Terminated
Has Results
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
20 Completed
Has Results
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.